BSD City, July 30, 2026 – Kaiser Cancer Center has officially opened at Banten International Education, Technology and Health (ETKI), also known as D-HUB Special Economic Zone (SEZ) in BSD City as an integrated women-centric cancer clinic providing cancer care that meets global standards. Through its Integrated Precision Oncology approach, Kaiser offers one-stop, end-to-end oncology care encompassing risk assessment, prevention, early detection, diagnosis, treatment, survivorship, and long-term patient support.
Kaiser is supported by a Multidisciplinary Team (MDT), precision medicine, advanced medical technologies, and access to international oncology experts. Kaiser is also the first healthcare provider in Indonesia to use the Siemens Healthineers e-health platform. These capabilities enable Kaiser to deliver faster diagnoses, more precise treatment planning, and an integrated cancer care experience centered on each patient’s individual needs.
Kaiser’s presence addresses the growing need for more integrated and personalized cancer care for women amid the high prevalence of breast and cervical cancer in Indonesia. According to data from BPJS Kesehatan, a significant increase in breast cancer cases, rising by hundreds of thousands between 2021 and 2025. The number of cases increased by approximately 860,000. From 1,080,031 cases in 2021 to 1,941,410 cases in 2025. These figures underscore the importance of integrated, international-standard cancer care that extends beyond treatment to include prevention, early detection, faster diagnosis, and integrated, personalized treatment planning.
- Adithia Kwee, Founder and Managing Director of Kaiser Cancer Center, said, “In line with the health transformation agenda advanced by the Indonesian Ministry of Health, Kaiser Cancer Center is committed to supporting the development of Indonesia’s cancer care capacity, from prevention and early detection to diagnosis, treatment, and ongoing patient support. Through integrated cancer care that meets global standards and is supported by advanced medical technologies, we aim to expand access to high-quality oncology services within Indonesia while supporting the government’s efforts to reduce the need for Indonesian patients to seek treatment overseas. We hope Kaiser can become a strategic partner to the government in building a stronger, more innovative, and patient-centered cancer care ecosystem.”
- I Gusti Ayu Nari Laksmi Dewi, Sp.B, Subsp.Onk(K), Surgical Oncologist at Kaiser Cancer Center, said, “Every patient’s condition is different, which means cancer treatment cannot follow a one-size-fits-all approach. Advances in oncology today require diagnostic precision, multidisciplinary collaboration, and the ability to develop treatment plans based on each patient’s individual characteristics. This is why we prioritize a more personalized and integrated approach, ensuring that every woman receives appropriate care and the best possible clinical outcomes.”
The development of Kaiser supports the transformation of Indonesia’s national healthcare system by strengthening access to high-quality oncology services within the country. Its presence also contributes to the development of an ecosystem connecting healthcare providers, technology, research, and strategic partners to drive sustainable healthcare innovation.
Lindawaty Chandra, Head of Business Entity for Development and Management of KEK ETKI Banten (BUPP) KEK ETKI BANTEN, said, “We congratulate Kaiser Cancer Center on its official operation at KEK ETKI Banten. Its presence marks an important milestone in strengthening an international-standard of healthcare ecosystem and supporting the realisation of Indonesia as a healthcare destination hub. We are continuously developing KEK ETKI Banten as an integrated ecosystem that connects healthcare facilities, medical research, technology, academia, and industry players. Kaiser complements this ecosystem by providing integrated, personalised, and patient-centred cancer care services. Going forward, we will continue to create opportunities for collaboration with various stakeholders and strategic partners to encourage innovation and investment that deliver tangible benefits for improving the quality of national healthcare services to international standards.”
As part of its commitment to promoting prevention and early detection, Kaiser has also formed a strategic collaboration with Lovepink Indonesia, the country’s largest community of breast cancer warriors and survivors. The collaboration aims to strengthen education for Indonesian women on the importance of understanding their bodies, undergoing early detection, and accessing information and support from the beginning of their cancer journey.
Dede Gracia, Chairwoman of Lovepink Indonesia, said, “No woman is ever truly prepared to hear a cancer diagnosis. However, every woman deserves an equal opportunity to find out early, receive the best possible care, and continue to have hope. Through this collaboration, we want to encourage more women to understand their bodies, undergo early detection, and believe that they do not have to face this journey alone.”
Through its integrated, preventive, personalized, and patient-centered approach, Kaiser provides more comprehensive cancer care for women while contributing to the development of a more innovative and globally competitive national healthcare system.
